Imcyse to Present Late-Breaking Abstract of its ImotopeTM-Based Antigen-Specific Immunotherapy for Autoimmune Diseases at ASIT 2020
Oral presentation during the session Tolerance Delivery Systems & Trial Design Optimization showcases the value the Company's novel approach to...